Literature DB >> 34269737

Psychopathology and Adaptive Functioning in Children, Adolescents, and Young Adults with Noonan Syndrome.

Chiara Davico1, Marta Borgogno1, Filippa Campagna1, Rossella D'Alessandro1, Federica Ricci1, Federico Amianto1, Alessandro Mussa2, Diana Carli2, Giovanni Battista Ferrero2, Benedetto Vitiello1.   

Abstract

OBJECTIVE: The objective of this study was to examine psychopathology and its impact on adaptive functioning in a sample of patients affected by Noonan syndrome (NS), a genetically heterogeneous condition with systemic manifestations.
METHOD: Forty-two subjects affected by NS (23 males and 19 females), aged 5 to 21 years (mean 12.6 ± SD 5.1), were assessed for nonverbal cognitive abilities, with dimensional measures of psychopathology, adaptive functioning, and family quality of life.
RESULTS: The nonverbal intelligence quotient (IQ) mean was 99.4 ± SD 22.2, with 3 subjects (8%, 95% confidence interval [CI], 1.6%-20.9%) showing cognitive impairment (IQ<70). The Parent Child Behavior Checklist (CBCL) total psychopathology score was in the clinical range in 10% of sample and borderline in another 10%. On the Conners' Parent Rating Scales, scores suggestive of attention-deficit/hyperactivity disorder (ADHD) were in the clinical range in 20%. On the autism quotient, autism spectrum disorder symptoms were reported in 10%. Higher scores on the Adaptive Behavioral Assessment System-Second Edition and on the World Health Organization Quality of Life (26 items) were associated with lower problems on the CBCL (r = -0.63, 95% CI, -0.78 to -0.40 and r = -0.48, 95% CI, -0.69 to -0.20, respectively).
CONCLUSION: Psychopathology was common in patients with NS and negatively correlated with global functioning and family quality of life. Treatable psychopathology, such as ADHD, may constitute a treatment target for improving adaptive functioning.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 34269737     DOI: 10.1097/DBP.0000000000000991

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  2 in total

1.  Epilepsy in a cohort of children with Noonan syndrome and related disorders.

Authors:  Chiara Davico; Rossella D'Alessandro; Marta Borgogno; Filippa Campagna; Francesca Torta; Federica Ricci; Federico Amianto; Roberta Vittorini; Diana Carli; Alessandro Mussa; Benedetto Vitiello; Giovanni Battista Ferrero
Journal:  Eur J Pediatr       Date:  2022-05-16       Impact factor: 3.860

2.  Cognitive Phenotype and Psychopathology in Noonan Syndrome Spectrum Disorders through Various Ras/MAPK Pathway Associated Gene Variants.

Authors:  Ellen Wingbermühle; Renée L Roelofs; Wouter Oomens; Jennifer Kramer; Jos M T Draaisma; Erika Leenders; Tjitske Kleefstra; Roy P C Kessels; Jos I M Egger
Journal:  J Clin Med       Date:  2022-08-13       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.